Thanks for stopping by our booth!
If you weren’t able to make it to World CB & CDx, see what you missed below.
To view materials showcased at World CB & CDx:
Download now
Together for a better healthcare journey
We are committed to providing unwavering support to our biopharma clients at every stage of the clinical trial process. Our aim is to deliver seamless end-to-end solutions without any compromises or unnecessary complexities. Our extensive portfolio includes a wide range of cfDNA and cfRNA NGS services, all backed by an exceptional project management team that sets us apart.
The Sysmex Inostics Team was excited to interact with booth visitors on how our comprehensive clinical trial services can address liquid biopsy needs in oncology!
We showcased the utility of plasma-based cfDNA diagnostic assays for optimizing oncology treatment!
Our expert delivered an insightful presentation on the use of cfHPV-DNA as a biomarker for HPV-associated OPSCC!
Our audience was engaged at the presentation of “The Rise of cfHPV-DNA as a Biomarker for HPV-Associated OPSCC”.
Plus, we participated in the games!
Expert presentation
The Rise of cfHPV-DNA as a Biomarker for HPV-Associated OPSCC
Presented by: Nishant Agrawal, MD, Professor of Surgery, Co-Director, Head and Neck Surgical Oncology Chief of Otolaryngology – Head and Neck Surgery, University of Chicago
Synopsis:
- Assess patients’ trial eligibility, by determining patients’ HPV status and subtype with a simple blood draw.
- Gain real-time insights into treatment response, by assessing dynamic changes in cfHPV-DNA quantitatively over the course of treatment.
- Detect recurrent disease — including distant recurrence — early, with detection that precedes the current standard of care.
World CB & CDx Summit Materials
Download the materials showcased at World CB & CDx.
Details about how we process your information are available in our Privacy Policy.